{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:33:49Z","timestamp":1790663629011,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["778003"],"award-info":[{"award-number":["778003"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s12035-019-1554-x","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T05:36:12Z","timestamp":1553578572000},"page":"6703-6715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis"],"prefix":"10.1007","volume":"56","author":[{"given":"Elena","family":"Abati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nereo","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-969X","authenticated-orcid":false,"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.71","journal-title":"Nat Rev Dis Primers"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162\u2013172. \n                    https:\/\/doi.org\/10.1056\/NEJMra1603471","journal-title":"N Engl J Med"},{"key":"1554_CR3","doi-asserted-by":"publisher","unstructured":"Miller RG, Mitchell JD, Moore DH (2012) Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst Rev:CD001447. \n                    https:\/\/doi.org\/10.1002\/14651858.CD001447.pub3","DOI":"10.1002\/14651858.CD001447.pub3"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.clinthera.2014.12.020","volume":"37","author":"M Bucchia","year":"2015","unstructured":"Bucchia M, Ramirez A, Parente V, Simone C, Nizzardo M, Magri F, Dametti S, Corti S (2015) Therapeutic development in amyotrophic lateral sclerosis. Clin Ther 37:668\u2013680. \n                    https:\/\/doi.org\/10.1016\/j.clinthera.2014.12.020","journal-title":"Clin Ther"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/21678421.2017.1369125","volume":"18","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi A, Andersen PM, Chandran S et al (2017) July 2017 ENCALS statement on edaravone. Amyotroph Lateral Scler Frontotemporal Degener 18:471\u2013474. \n                    https:\/\/doi.org\/10.1080\/21678421.2017.1369125","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s12035-017-0532-4","volume":"55","author":"SG Crisafulli","year":"2018","unstructured":"Crisafulli SG, Brajkovic S, Cipolat Mis MS, Parente V, Corti S (2018) Therapeutic strategies under development targeting inflammatory mechanisms in amyotrophic lateral sclerosis. Mol Neurobiol 55:2789\u20132813. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0532-4","journal-title":"Mol Neurobiol"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1007\/s00018-014-1613-4","volume":"71","author":"I Faravelli","year":"2014","unstructured":"Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, Comi GP, Corti S (2014) Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation. Cell Mol Life Sci 71:3257\u20133268. \n                    https:\/\/doi.org\/10.1007\/s00018-014-1613-4","journal-title":"Cell Mol Life Sci"},{"key":"1554_CR8","doi-asserted-by":"publisher","unstructured":"Abati E, Bresolin N, Pietro CG, Corti S (2018) Preconditioning and cellular engineering to increase the survival of transplanted neural stem cells for motor neuron disease therapy. Mol Neurobiol. \n                    https:\/\/doi.org\/10.1007\/s12035-018-1305-4","DOI":"10.1007\/s12035-018-1305-4"},{"key":"1554_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17482960802160370","volume":"10","author":"SA Sakowski","year":"2009","unstructured":"Sakowski SA, Schuyler AD, Feldman EL (2009) Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:63\u201373. \n                    https:\/\/doi.org\/10.1080\/17482960802160370","journal-title":"Amyotroph Lateral Scler"},{"key":"1554_CR10","doi-asserted-by":"publisher","unstructured":"Javorkova E, Matejckova N, Zajicova A, Hermankova B, Hajkova M, Bohacova P, Kossl J, Krulova M et al (2018) Immunomodulatory properties of bone marrow mesenchymal stem cells from patients with amyotrophic lateral sclerosis and healthy donors. J NeuroImmune Pharmacol. \n                    https:\/\/doi.org\/10.1007\/s11481-018-9812-7","DOI":"10.1007\/s11481-018-9812-7"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","volume":"71","author":"F Rizzo","year":"2014","unstructured":"Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E (2014) Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci 71:999\u20131015. \n                    https:\/\/doi.org\/10.1007\/s00018-013-1480-4","journal-title":"Cell Mol Life Sci"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14712598.2018.1503248","volume":"18","author":"L Mazzini","year":"2018","unstructured":"Mazzini L, Ferrari D, Andjus PR, Buzanska L, Cantello R, de Marchi F, Gelati M, Giniatullin R et al (2018) Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opin Biol Ther 18:865\u2013881. \n                    https:\/\/doi.org\/10.1080\/14712598.2018.1503248","journal-title":"Expert Opin Biol Ther"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/WCO.0000000000000598","volume":"31","author":"RH Baloh","year":"2018","unstructured":"Baloh RH, Glass JD, Svendsen CN (2018) Stem cell transplantation for amyotrophic lateral sclerosis. Curr Opin Neurol 31:655\u2013661. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000598","journal-title":"Curr Opin Neurol"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.pmed.0040039","volume":"4","author":"J Yan","year":"2007","unstructured":"Yan J, Xu L, Welsh AM, Hatfield G, Hazel T, Johe K, Koliatsos VE (2007) Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 4:e39. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.0040039","journal-title":"PLoS Med"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cne.22022","volume":"514","author":"L Xu","year":"2009","unstructured":"Xu L, Ryugo DK, Pongstaporn T, Johe K, Koliatsos VE (2009) Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J Comp Neurol 514:297\u2013309. \n                    https:\/\/doi.org\/10.1002\/cne.22022","journal-title":"J Comp Neurol"},{"key":"1554_CR16","doi-asserted-by":"publisher","first-page":"11761","DOI":"10.1523\/JNEUROSCI.2734-09.2009","volume":"29","author":"S Corti","year":"2009","unstructured":"Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, del Bo R, Papadimitriou D, Locatelli F et al (2009) Motoneuron transplantation rescues the phenotype of SMARD1 (spinal muscular atrophy with respiratory distress type 1). J Neurosci 29:11761\u201311771. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2734-09.2009","journal-title":"J Neurosci"},{"key":"1554_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/jnr.22288","volume":"88","author":"JF Bonner","year":"2010","unstructured":"Bonner JF, Blesch A, Neuhuber B, Fischer I (2010) Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. J Neurosci Res 88:1182\u20131192. \n                    https:\/\/doi.org\/10.1002\/jnr.22288","journal-title":"J Neurosci Res"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2174\/187152710791292666","volume":"9","author":"V Silani","year":"2010","unstructured":"Silani V, Calzarossa C, Cova L, Ticozzi N (2010) Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? CNS Neurol Disord Drug Targets 9:314\u2013324","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nbt.1957","volume":"29","author":"AM Haidet-Phillips","year":"2011","unstructured":"Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song SW, Likhite S et al (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29:824\u2013828. \n                    https:\/\/doi.org\/10.1038\/nbt.1957","journal-title":"Nat Biotechnol"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1086071","volume":"302","author":"AM Clement","year":"2003","unstructured":"Clement AM, Nguyen MD, Roberts EA et al (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113\u2013117. \n                    https:\/\/doi.org\/10.1126\/science.1086071","journal-title":"Science"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"e25968","DOI":"10.1371\/journal.pone.0025968","volume":"6","author":"AC Lepore","year":"2011","unstructured":"Lepore AC, O\u2019Donnell J, Kim AS et al (2011) Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 6:e25968. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0025968","journal-title":"PLoS One"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4252\/wjsc.v7.i2.380","volume":"7","author":"C Nicaise","year":"2015","unstructured":"Nicaise C, Mitrecic D, Falnikar A, Lepore AC (2015) Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells 7:380\u2013398. \n                    https:\/\/doi.org\/10.4252\/wjsc.v7.i2.380","journal-title":"World J Stem Cells"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000107704","volume":"4","author":"LR Fischer","year":"2007","unstructured":"Fischer LR, Glass JD (2007) Axonal degeneration in motor neuron disease. Neurodegener Dis 4:431\u2013442. \n                    https:\/\/doi.org\/10.1159\/000107704","journal-title":"Neurodegener Dis"},{"key":"1554_CR24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK, Llad\u00f3 J, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839\u2013842. \n                    https:\/\/doi.org\/10.1126\/science.1086137","journal-title":"Science"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"25960","DOI":"10.1038\/srep25960","volume":"6","author":"I Allodi","year":"2016","unstructured":"Allodi I, Comley L, Nichterwitz S, Nizzardo M, Simone C, Benitez JA, Cao M, Corti S et al (2016) Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci Rep 6:25960. \n                    https:\/\/doi.org\/10.1038\/srep25960","journal-title":"Sci Rep"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","volume":"2","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2:e689. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0000689","journal-title":"PLoS One"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.addr.2017.07.012","volume":"120","author":"X Li","year":"2017","unstructured":"Li X, Hacker M (2017) Molecular imaging in stem cell-based therapies of cardiac diseases. Adv Drug Deliv Rev 120:71\u201388. \n                    https:\/\/doi.org\/10.1016\/j.addr.2017.07.012","journal-title":"Adv Drug Deliv Rev"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2016.07.028","volume":"105","author":"P Moshayedi","year":"2016","unstructured":"Moshayedi P, Nih LR, Llorente IL, Berg AR, Cinkornpumin J, Lowry WE, Segura T, Carmichael ST (2016) Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials 105:145\u2013155. \n                    https:\/\/doi.org\/10.1016\/j.biomaterials.2016.07.028","journal-title":"Biomaterials"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1517\/17460441.2015.1037737","volume":"10","author":"S Corti","year":"2015","unstructured":"Corti S, Faravelli I, Cardano M, Conti L (2015) Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery. Expert Opin Drug Discovery 10:615\u2013629. \n                    https:\/\/doi.org\/10.1517\/17460441.2015.1037737","journal-title":"Expert Opin Drug Discovery"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/cne.23578","volume":"522","author":"D Sareen","year":"2014","unstructured":"Sareen D, Gowing G, Sahabian A, Staggenborg K, Paradis R, Avalos P, Latter J, Ornelas L et al (2014) Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol 522:2707\u20132728. \n                    https:\/\/doi.org\/10.1002\/cne.23578","journal-title":"J Comp Neurol"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/hmg\/ddw163","volume":"25","author":"M Nizzardo","year":"2016","unstructured":"Nizzardo M, Bucchia M, Ramirez A, Trombetta E, Bresolin N, Comi GP, Corti S (2016) iPSC-derived LewisX+CXCR4+\u03b21-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models. Hum Mol Genet 25:3152\u20133163. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddw163","journal-title":"Hum Mol Genet"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/hmg\/ddt425","volume":"23","author":"M Nizzardo","year":"2014","unstructured":"Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, Faravelli I, Zanetta C et al (2014) Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model. Hum Mol Genet 23:342\u2013354. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt425","journal-title":"Hum Mol Genet"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/5584_2018_173","volume":"1079","author":"C Kavyasudha","year":"2018","unstructured":"Kavyasudha C, Macrin D, ArulJothi KN et al (2018) Clinical applications of induced pluripotent stem cells - Stato Attuale. Adv Exp Med Biol 1079:127\u2013149. \n                    https:\/\/doi.org\/10.1007\/5584_2018_173","journal-title":"Adv Exp Med Biol"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nbt.4127","volume":"36","author":"AA Mansour","year":"2018","unstructured":"Mansour AA, Gon\u00e7alves JT, Bloyd CW et al (2018) An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol 36:432\u2013441. \n                    https:\/\/doi.org\/10.1038\/nbt.4127","journal-title":"Nat Biotechnol"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev-cellbio-100913-013132","volume":"30","author":"P Bianco","year":"2014","unstructured":"Bianco P (2014) \u201cMesenchymal\u201d stem cells. Annu Rev Cell Dev Biol 30:677\u2013704. \n                    https:\/\/doi.org\/10.1146\/annurev-cellbio-100913-013132","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1554_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jnc.14339","volume":"146","author":"M Lindner","year":"2018","unstructured":"Lindner M, Klotz L, Wiendl H (2018) Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity. J Neurochem 146:122\u2013132. \n                    https:\/\/doi.org\/10.1111\/jnc.14339","journal-title":"J Neurochem"},{"key":"1554_CR37","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1093\/hmg\/ddq293","volume":"19","author":"S Corti","year":"2010","unstructured":"Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, Simone C, Falcone M, Riboldi G et al (2010) Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Hum Mol Genet 19:3782\u20133796. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddq293","journal-title":"Hum Mol Genet"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.4155\/tde.13.111","volume":"4","author":"JJ Lamanna","year":"2013","unstructured":"Lamanna JJ, Miller JH, Riley JP, Hurtig CV, Boulis NM (2013) Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application. Ther Deliv 4:1397\u20131410. \n                    https:\/\/doi.org\/10.4155\/tde.13.111","journal-title":"Ther Deliv"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10439-017-1960-z","volume":"46","author":"A Squires","year":"2018","unstructured":"Squires A, Oshinski JN, Boulis NM, Tse ZTH (2018) SpinoBot: an MRI-guided needle positioning system for spinal cellular therapeutics. Ann Biomed Eng 46:475\u2013487. \n                    https:\/\/doi.org\/10.1007\/s10439-017-1960-z","journal-title":"Ann Biomed Eng"},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"CR Freed","year":"2001","unstructured":"Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H et al (2001) Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl J Med 344:710\u2013719. \n                    https:\/\/doi.org\/10.1056\/NEJM200103083441002","journal-title":"N Engl J Med"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","volume":"87","author":"NN Madigan","year":"2016","unstructured":"Staff NP, Madigan NN, Morris J et al (2016) Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology 87:2230\u20132234. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000003359","journal-title":"Neurology"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.12688\/f1000research.10955.1","volume":"6","author":"P Robey","year":"2017","unstructured":"Robey P (2017) \u201cMesenchymal stem cells\u201d: fact or fiction, and implications in their therapeutic use. F1000Res 6:524. \n                    https:\/\/doi.org\/10.12688\/f1000research.10955.1","journal-title":"F1000Res"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/d41586-018-06756-9","volume":"561","author":"D Sipp","year":"2018","unstructured":"Sipp D, Robey PG, Turner L (2018) Clear up this stem-cell mess. Nature 561:455\u2013457. \n                    https:\/\/doi.org\/10.1038\/d41586-018-06756-9","journal-title":"Nature"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/14660820310014653","volume":"4","author":"L Mazzini","year":"2003","unstructured":"Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, Pastore I, Marasso R et al (2003) Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4:158\u2013161","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13024-017-0227-3","volume":"12","author":"Y Ciervo","year":"2017","unstructured":"Ciervo Y, Ning K, Jun X, Shaw PJ, Mead RJ (2017) Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis. Mol Neurodegener 12:85. \n                    https:\/\/doi.org\/10.1186\/s13024-017-0227-3","journal-title":"Mol Neurodegener"},{"key":"1554_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1182\/blood-2007-07-103697","volume":"112","author":"F Ng","year":"2008","unstructured":"Ng F, Boucher S, Koh S, Sastry KSR, Chase L, Lakshmipathy U, Choong C, Yang Z et al (2008) PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112:295\u2013307. \n                    https:\/\/doi.org\/10.1182\/blood-2007-07-103697","journal-title":"Blood"},{"key":"1554_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3727\/096368916X693716","volume":"26","author":"E Sykov\u00e1","year":"2017","unstructured":"Sykov\u00e1 E, Rychmach P, Drahor\u00e1dov\u00e1 I, Konr\u00e1dov\u00e1 \u0160I, R\u016f\u017ei\u010dkov\u00e1 K, Vo\u0159\u00ed\u0161ek I, Forostyak S, Homola A et al (2017) Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial. Cell Transplant 26:647\u2013658. \n                    https:\/\/doi.org\/10.3727\/096368916X693716","journal-title":"Cell Transplant"},{"key":"1554_CR48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5966\/sctm.2014-0212","volume":"4","author":"K-W Oh","year":"2015","unstructured":"Oh K-W, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS et al (2015) Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med 4:590\u2013597. \n                    https:\/\/doi.org\/10.5966\/sctm.2014-0212","journal-title":"Stem Cells Transl Med"},{"key":"1554_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13287-017-0692-1","volume":"8","author":"Y Gothelf","year":"2017","unstructured":"Gothelf Y, Kaspi H, Abramov N, Aricha R (2017) miRNA profiling of NurOwn\u00ae: mesenchymal stem cells secreting neurotrophic factors. Stem Cell Res Ther 8:249. \n                    https:\/\/doi.org\/10.1186\/s13287-017-0692-1","journal-title":"Stem Cell Res Ther"},{"key":"1554_CR50","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","volume":"73","author":"P Petrou","year":"2016","unstructured":"Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T et al (2016) Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials. JAMA Neurol 73:337\u2013344. \n                    https:\/\/doi.org\/10.1001\/jamaneurol.2015.4321","journal-title":"JAMA Neurol"},{"key":"1554_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.stem.2012.05.010","volume":"10","author":"GQ Daley","year":"2012","unstructured":"Daley GQ (2012) The promise and perils of stem cell therapeutics. Cell Stem Cell 10:740\u2013749. \n                    https:\/\/doi.org\/10.1016\/j.stem.2012.05.010","journal-title":"Cell Stem Cell"},{"key":"1554_CR52","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak \u00d6, Brogdon JL, Pruteanu-Malinici I et al (2017) Chimeric antigen receptor T cells in refractory B-cell lymphomas. N Engl J Med 377:2545\u20132554. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1708566","journal-title":"N Engl J Med"},{"key":"1554_CR53","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1093\/brain\/awh273","volume":"127","author":"S Corti","year":"2004","unstructured":"Corti S, Locatelli F, Donadoni C, Guglieri M, Papadimitriou D, Strazzer S, del Bo R, Comi GP (2004) Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 127:2518\u20132532. \n                    https:\/\/doi.org\/10.1093\/brain\/awh273","journal-title":"Brain"},{"key":"1554_CR54","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1073\/pnas.0607423103","volume":"103","author":"DR Beers","year":"2006","unstructured":"Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR et al (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103:16021\u201316026. \n                    https:\/\/doi.org\/10.1073\/pnas.0607423103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1554_CR55","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/WCO.0000000000000599","volume":"31","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Simpson EP, Appel SH (2018) Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol 31:635\u2013639. \n                    https:\/\/doi.org\/10.1097\/WCO.0000000000000599","journal-title":"Curr Opin Neurol"},{"key":"1554_CR56","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","volume":"7","author":"JA Bluestone","year":"2015","unstructured":"Bluestone JA, Buckner JH, Fitch M, Gitelman SE, Gupta S, Hellerstein MK, Herold KC, Lares A et al (2015) Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci Transl Med 7:315ra189\u2013315ra189. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aad4134","journal-title":"Sci Transl Med"},{"key":"1554_CR57","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"DR Beers","year":"2008","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Appel SH (2008) CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci 105:15558\u201315563. \n                    https:\/\/doi.org\/10.1073\/pnas.0807419105","journal-title":"Proc Natl Acad Sci"},{"key":"1554_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","volume":"48","author":"W Zhao","year":"2012","unstructured":"Zhao W, Beers DR, Liao B, Henkel JS, Appel SH (2012) Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis 48:418\u2013428. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2012.07.008","journal-title":"Neurobiol Dis"},{"key":"1554_CR59","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","volume":"5","author":"JR Thonhoff","year":"2018","unstructured":"Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, Cudkowicz ME, Appel SH (2018) Expanded autologous regulatory T-lymphocyte infusions in ALS: a phase I, first-in-human study. Neurol Neuroimmunol Neuroinflamm 5:e465. \n                    https:\/\/doi.org\/10.1212\/NXI.0000000000000465","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1554_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","volume":"13","author":"L Mazzini","year":"2015","unstructured":"Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L et al (2015) Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med 13:17. \n                    https:\/\/doi.org\/10.1186\/s12967-014-0371-2","journal-title":"J Transl Med"},{"key":"1554_CR61","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/stem.1079","volume":"30","author":"JD Glass","year":"2012","unstructured":"Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL (2012) Lumbar Intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 30:1144\u20131151. \n                    https:\/\/doi.org\/10.1002\/stem.1079","journal-title":"Stem Cells"},{"key":"1554_CR62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ana.24113","volume":"75","author":"EL Feldman","year":"2014","unstructured":"Feldman EL, Boulis NM, Hur J, Johe K, Rutkove SB, Federici T, Polak M, Bordeau J et al (2014) Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol 75:363\u2013373. \n                    https:\/\/doi.org\/10.1002\/ana.24113","journal-title":"Ann Neurol"},{"key":"1554_CR63","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1212\/WNL.0000000000002889","volume":"87","author":"JD Glass","year":"2016","unstructured":"Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C et al (2016) Transplantation of spinal cord\u2013derived neural stem cells for ALS. Neurology 87:392\u2013400. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002889","journal-title":"Neurology"},{"key":"1554_CR64","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/term.223","volume":"4","author":"X Guo","year":"2010","unstructured":"Guo X, Johe K, Molnar P, Davis H, Hickman J (2010) Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. J Tissue Eng Regen Med 4:181\u2013193. \n                    https:\/\/doi.org\/10.1002\/term.223","journal-title":"J Tissue Eng Regen Med"},{"key":"1554_CR65","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","volume":"82","author":"L Xu","year":"2006","unstructured":"Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE (2006) Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82:865\u2013875. \n                    https:\/\/doi.org\/10.1097\/01.tp.0000235532.00920.7a","journal-title":"Transplantation"},{"key":"1554_CR66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","volume":"494","author":"L Xu","year":"2011","unstructured":"Xu L, Shen P, Hazel T, Johe K, Koliatsos VE (2011) Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett 494:222\u2013226. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2011.03.017","journal-title":"Neurosci Lett"},{"key":"1554_CR67","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/21678421.2017.1421666","volume":"19","author":"CN Fournier","year":"2018","unstructured":"Fournier CN, Schoenfeld D, Berry JD, Cudkowicz ME, Chan J, Quinn C, Brown RH, Salameh JS et al (2018) An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 19:242\u2013249. \n                    https:\/\/doi.org\/10.1080\/21678421.2017.1421666","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1554_CR68","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/stem.2825","volume":"36","author":"GM Thomsen","year":"2018","unstructured":"Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, Vit JP, Godoy M et al (2018) Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells 36:1122\u20131131. \n                    https:\/\/doi.org\/10.1002\/stem.2825","journal-title":"Stem Cells"},{"key":"1554_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrneurol.2011.191","volume":"8","author":"NM Boulis","year":"2012","unstructured":"Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL (2012) Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 8:172\u2013176. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2011.191","journal-title":"Nat Rev Neurol"},{"key":"1554_CR70","doi-asserted-by":"publisher","unstructured":"(2018) Voices: crossing the valley of death. Cell Stem Cell 23:639\u2013641. \n                    https:\/\/doi.org\/10.1016\/J.STEM.2018.10.021","DOI":"10.1016\/J.STEM.2018.10.021"},{"key":"1554_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/scrt474","volume":"5","author":"NM King","year":"2014","unstructured":"King NM, Perrin J (2014) Ethical issues in stem cell research and therapy. Stem Cell Res Ther 5:85. \n                    https:\/\/doi.org\/10.1186\/scrt474","journal-title":"Stem Cell Res Ther"},{"key":"1554_CR72","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1371\/journal.pmed.0040324","volume":"4","author":"GE Henderson","year":"2007","unstructured":"Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NMP et al (2007) Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 4:e324. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.0040324","journal-title":"PLoS Med"},{"key":"1554_CR73","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1056\/NEJMc1600188","volume":"375","author":"AL Berkowitz","year":"2016","unstructured":"Berkowitz AL, Miller MB, Mir SA, Cagney D, Chavakula V, Guleria I, Aizer A, Ligon KL et al (2016) Glioproliferative lesion of the spinal cord as a complication of \u201cstem-cell tourism\u201d. N Engl J Med 375:196\u2013198. \n                    https:\/\/doi.org\/10.1056\/NEJMc1600188","journal-title":"N Engl J Med"},{"key":"1554_CR74","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1602\/neurorx.1.4.472","volume":"1","author":"RA Barker","year":"2004","unstructured":"Barker RA, Widner H (2004) Immune problems in central nervous system cell therapy. NeuroRX 1:472\u2013481. \n                    https:\/\/doi.org\/10.1602\/neurorx.1.4.472","journal-title":"NeuroRX"},{"key":"1554_CR75","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.expneurol.2016.12.011","volume":"289","author":"AK Srivastava","year":"2017","unstructured":"Srivastava AK, Gross SK, Almad AA, Bulte CA, Maragakis NJ, Bulte JWM (2017) Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 289:96\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.expneurol.2016.12.011","journal-title":"Exp Neurol"},{"key":"1554_CR76","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B et al (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88:2302\u20132309. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"key":"1554_CR77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2015.04.032","volume":"353","author":"PA McCombe","year":"2015","unstructured":"McCombe PA, Pfluger C, Singh P et al (2015) Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. J Neurol Sci 353:122\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.jns.2015.04.032","journal-title":"J Neurol Sci"},{"key":"1554_CR78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mus.26087","volume":"58","author":"ML Escorcio-Bezerra","year":"2018","unstructured":"Escorcio-Bezerra ML, Abrahao A, Nunes KF, de Oliveira Braga NI, Oliveira ASB, Zinman L, Manzano GM (2018) Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis. Muscle Nerve 58:204\u2013212. \n                    https:\/\/doi.org\/10.1002\/mus.26087","journal-title":"Muscle Nerve"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1554-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1554-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1554-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:31:18Z","timestamp":1585096278000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1554-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1554-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}